Global Personalized Medicines Market Research Report 2026(Status and Outlook)
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Personalized Medicines market size was estimated at USD 319550.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Personalized Medicines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Personalized Medicines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Personalized Medicines market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Personalized Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Personalized Medicines market size was estimated at USD 319550.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Personalized Medicines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Personalized Medicines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Personalized Medicines market.
Global Personalized Medicines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- 3G Biotech
- Quest Diagnostics
- Laboratory Corporation of America
- Abbott
- Agendia NV
- Asuragen Inc
- Becton Dickinson
- CardioDx Inc.
- Foundation Medicine
- Qiagen
- Siemens Healthcare
- Amgen
- Bristol-Myers Squibb
- GE Healthcare
- Pfizer
- Sanofi
- 23andMe
- Illumina
Market Segmentation (by Type)
- PM Diagnostics
- PM Therapeutics
- Personalized Medical Care
- Personalized Nutrition & Wellness
Market Segmentation (by Application)
- Hospitals Pharmacies
- Retail Pharmacies
- Dietary Care Centers
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Personalized Medicines Market
Overview of the regional outlook of the Personalized Medicines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Personalized Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Personalized Medicines
1.2 Key Market Segments
1.2.1 Personalized Medicines Segment by Type
1.2.2 Personalized Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERSONALIZED MEDICINES MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERSONALIZED MEDICINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Personalized Medicines Product Life Cycle
3.3 Global Personalized Medicines Revenue Market Share by Company (2020-2025)
3.4 Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Personalized Medicines Market Competitive Situation and Trends
3.6.1 Personalized Medicines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Personalized Medicines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINES VALUE CHAIN ANALYSIS
4.1 Personalized Medicines Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERSONALIZED MEDICINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Medicines Market Porter's Five Forces Analysis
6 PERSONALIZED MEDICINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicines Market by Type (2020-2025)
6.3 Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
7 PERSONALIZED MEDICINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicines Market Size (M USD) by Application (2020-2025)
7.3 Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
8 PERSONALIZED MEDICINES MARKET SEGMENTATION BY REGION
8.1 Global Personalized Medicines Market Size by Region
8.1.1 Global Personalized Medicines Market Size by Region
8.1.2 Global Personalized Medicines Market Size Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicines Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicines Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicines Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicines Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicines Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 3G Biotech
9.1.1 3G Biotech Basic Information
9.1.2 3G Biotech Personalized Medicines Product Overview
9.1.3 3G Biotech Personalized Medicines Product Market Performance
9.1.4 3G Biotech SWOT Analysis
9.1.5 3G Biotech Business Overview
9.1.6 3G Biotech Recent Developments
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Basic Information
9.2.2 Quest Diagnostics Personalized Medicines Product Overview
9.2.3 Quest Diagnostics Personalized Medicines Product Market Performance
9.2.4 Quest Diagnostics SWOT Analysis
9.2.5 Quest Diagnostics Business Overview
9.2.6 Quest Diagnostics Recent Developments
9.3 Laboratory Corporation of America
9.3.1 Laboratory Corporation of America Basic Information
9.3.2 Laboratory Corporation of America Personalized Medicines Product Overview
9.3.3 Laboratory Corporation of America Personalized Medicines Product Market Performance
9.3.4 Laboratory Corporation of America SWOT Analysis
9.3.5 Laboratory Corporation of America Business Overview
9.3.6 Laboratory Corporation of America Recent Developments
9.4 Abbott
9.4.1 Abbott Basic Information
9.4.2 Abbott Personalized Medicines Product Overview
9.4.3 Abbott Personalized Medicines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Agendia NV
9.5.1 Agendia NV Basic Information
9.5.2 Agendia NV Personalized Medicines Product Overview
9.5.3 Agendia NV Personalized Medicines Product Market Performance
9.5.4 Agendia NV Business Overview
9.5.5 Agendia NV Recent Developments
9.6 Asuragen Inc
9.6.1 Asuragen Inc Basic Information
9.6.2 Asuragen Inc Personalized Medicines Product Overview
9.6.3 Asuragen Inc Personalized Medicines Product Market Performance
9.6.4 Asuragen Inc Business Overview
9.6.5 Asuragen Inc Recent Developments
9.7 Becton Dickinson
9.7.1 Becton Dickinson Basic Information
9.7.2 Becton Dickinson Personalized Medicines Product Overview
9.7.3 Becton Dickinson Personalized Medicines Product Market Performance
9.7.4 Becton Dickinson Business Overview
9.7.5 Becton Dickinson Recent Developments
9.8 CardioDx Inc.
9.8.1 CardioDx Inc. Basic Information
9.8.2 CardioDx Inc. Personalized Medicines Product Overview
9.8.3 CardioDx Inc. Personalized Medicines Product Market Performance
9.8.4 CardioDx Inc. Business Overview
9.8.5 CardioDx Inc. Recent Developments
9.9 Foundation Medicine
9.9.1 Foundation Medicine Basic Information
9.9.2 Foundation Medicine Personalized Medicines Product Overview
9.9.3 Foundation Medicine Personalized Medicines Product Market Performance
9.9.4 Foundation Medicine Business Overview
9.9.5 Foundation Medicine Recent Developments
9.10 Qiagen
9.10.1 Qiagen Basic Information
9.10.2 Qiagen Personalized Medicines Product Overview
9.10.3 Qiagen Personalized Medicines Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Siemens Healthcare
9.11.1 Siemens Healthcare Basic Information
9.11.2 Siemens Healthcare Personalized Medicines Product Overview
9.11.3 Siemens Healthcare Personalized Medicines Product Market Performance
9.11.4 Siemens Healthcare Business Overview
9.11.5 Siemens Healthcare Recent Developments
9.12 Amgen
9.12.1 Amgen Basic Information
9.12.2 Amgen Personalized Medicines Product Overview
9.12.3 Amgen Personalized Medicines Product Market Performance
9.12.4 Amgen Business Overview
9.12.5 Amgen Recent Developments
9.13 Bristol-Myers Squibb
9.13.1 Bristol-Myers Squibb Basic Information
9.13.2 Bristol-Myers Squibb Personalized Medicines Product Overview
9.13.3 Bristol-Myers Squibb Personalized Medicines Product Market Performance
9.13.4 Bristol-Myers Squibb Business Overview
9.13.5 Bristol-Myers Squibb Recent Developments
9.14 GE Healthcare
9.14.1 GE Healthcare Basic Information
9.14.2 GE Healthcare Personalized Medicines Product Overview
9.14.3 GE Healthcare Personalized Medicines Product Market Performance
9.14.4 GE Healthcare Business Overview
9.14.5 GE Healthcare Recent Developments
9.15 Pfizer
9.15.1 Pfizer Basic Information
9.15.2 Pfizer Personalized Medicines Product Overview
9.15.3 Pfizer Personalized Medicines Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Sanofi
9.16.1 Sanofi Basic Information
9.16.2 Sanofi Personalized Medicines Product Overview
9.16.3 Sanofi Personalized Medicines Product Market Performance
9.16.4 Sanofi Business Overview
9.16.5 Sanofi Recent Developments
9.17 23andMe
9.17.1 23andMe Basic Information
9.17.2 23andMe Personalized Medicines Product Overview
9.17.3 23andMe Personalized Medicines Product Market Performance
9.17.4 23andMe Business Overview
9.17.5 23andMe Recent Developments
9.18 Illumina
9.18.1 Illumina Basic Information
9.18.2 Illumina Personalized Medicines Product Overview
9.18.3 Illumina Personalized Medicines Product Market Performance
9.18.4 Illumina Business Overview
9.18.5 Illumina Recent Developments
10 PERSONALIZED MEDICINES MARKET FORECAST BY REGION
10.1 Global Personalized Medicines Market Size Forecast
10.2 Global Personalized Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Personalized Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Personalized Medicines Market Size Forecast by Region
10.2.4 South America Personalized Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Personalized Medicines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Personalized Medicines Market Forecast by Type (2026-2035)
11.1.1 Global Personalized Medicines Market Size Forecast by Type (2026-2035)
11.2 Global Personalized Medicines Market Forecast by Application (2026-2035)
11.2.1 Global Personalized Medicines Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Personalized Medicines
1.2 Key Market Segments
1.2.1 Personalized Medicines Segment by Type
1.2.2 Personalized Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERSONALIZED MEDICINES MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERSONALIZED MEDICINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Personalized Medicines Product Life Cycle
3.3 Global Personalized Medicines Revenue Market Share by Company (2020-2025)
3.4 Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Personalized Medicines Market Competitive Situation and Trends
3.6.1 Personalized Medicines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Personalized Medicines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINES VALUE CHAIN ANALYSIS
4.1 Personalized Medicines Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERSONALIZED MEDICINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Medicines Market Porter's Five Forces Analysis
6 PERSONALIZED MEDICINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicines Market by Type (2020-2025)
6.3 Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
7 PERSONALIZED MEDICINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicines Market Size (M USD) by Application (2020-2025)
7.3 Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
8 PERSONALIZED MEDICINES MARKET SEGMENTATION BY REGION
8.1 Global Personalized Medicines Market Size by Region
8.1.1 Global Personalized Medicines Market Size by Region
8.1.2 Global Personalized Medicines Market Size Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicines Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicines Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicines Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicines Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicines Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 3G Biotech
9.1.1 3G Biotech Basic Information
9.1.2 3G Biotech Personalized Medicines Product Overview
9.1.3 3G Biotech Personalized Medicines Product Market Performance
9.1.4 3G Biotech SWOT Analysis
9.1.5 3G Biotech Business Overview
9.1.6 3G Biotech Recent Developments
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Basic Information
9.2.2 Quest Diagnostics Personalized Medicines Product Overview
9.2.3 Quest Diagnostics Personalized Medicines Product Market Performance
9.2.4 Quest Diagnostics SWOT Analysis
9.2.5 Quest Diagnostics Business Overview
9.2.6 Quest Diagnostics Recent Developments
9.3 Laboratory Corporation of America
9.3.1 Laboratory Corporation of America Basic Information
9.3.2 Laboratory Corporation of America Personalized Medicines Product Overview
9.3.3 Laboratory Corporation of America Personalized Medicines Product Market Performance
9.3.4 Laboratory Corporation of America SWOT Analysis
9.3.5 Laboratory Corporation of America Business Overview
9.3.6 Laboratory Corporation of America Recent Developments
9.4 Abbott
9.4.1 Abbott Basic Information
9.4.2 Abbott Personalized Medicines Product Overview
9.4.3 Abbott Personalized Medicines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Agendia NV
9.5.1 Agendia NV Basic Information
9.5.2 Agendia NV Personalized Medicines Product Overview
9.5.3 Agendia NV Personalized Medicines Product Market Performance
9.5.4 Agendia NV Business Overview
9.5.5 Agendia NV Recent Developments
9.6 Asuragen Inc
9.6.1 Asuragen Inc Basic Information
9.6.2 Asuragen Inc Personalized Medicines Product Overview
9.6.3 Asuragen Inc Personalized Medicines Product Market Performance
9.6.4 Asuragen Inc Business Overview
9.6.5 Asuragen Inc Recent Developments
9.7 Becton Dickinson
9.7.1 Becton Dickinson Basic Information
9.7.2 Becton Dickinson Personalized Medicines Product Overview
9.7.3 Becton Dickinson Personalized Medicines Product Market Performance
9.7.4 Becton Dickinson Business Overview
9.7.5 Becton Dickinson Recent Developments
9.8 CardioDx Inc.
9.8.1 CardioDx Inc. Basic Information
9.8.2 CardioDx Inc. Personalized Medicines Product Overview
9.8.3 CardioDx Inc. Personalized Medicines Product Market Performance
9.8.4 CardioDx Inc. Business Overview
9.8.5 CardioDx Inc. Recent Developments
9.9 Foundation Medicine
9.9.1 Foundation Medicine Basic Information
9.9.2 Foundation Medicine Personalized Medicines Product Overview
9.9.3 Foundation Medicine Personalized Medicines Product Market Performance
9.9.4 Foundation Medicine Business Overview
9.9.5 Foundation Medicine Recent Developments
9.10 Qiagen
9.10.1 Qiagen Basic Information
9.10.2 Qiagen Personalized Medicines Product Overview
9.10.3 Qiagen Personalized Medicines Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Siemens Healthcare
9.11.1 Siemens Healthcare Basic Information
9.11.2 Siemens Healthcare Personalized Medicines Product Overview
9.11.3 Siemens Healthcare Personalized Medicines Product Market Performance
9.11.4 Siemens Healthcare Business Overview
9.11.5 Siemens Healthcare Recent Developments
9.12 Amgen
9.12.1 Amgen Basic Information
9.12.2 Amgen Personalized Medicines Product Overview
9.12.3 Amgen Personalized Medicines Product Market Performance
9.12.4 Amgen Business Overview
9.12.5 Amgen Recent Developments
9.13 Bristol-Myers Squibb
9.13.1 Bristol-Myers Squibb Basic Information
9.13.2 Bristol-Myers Squibb Personalized Medicines Product Overview
9.13.3 Bristol-Myers Squibb Personalized Medicines Product Market Performance
9.13.4 Bristol-Myers Squibb Business Overview
9.13.5 Bristol-Myers Squibb Recent Developments
9.14 GE Healthcare
9.14.1 GE Healthcare Basic Information
9.14.2 GE Healthcare Personalized Medicines Product Overview
9.14.3 GE Healthcare Personalized Medicines Product Market Performance
9.14.4 GE Healthcare Business Overview
9.14.5 GE Healthcare Recent Developments
9.15 Pfizer
9.15.1 Pfizer Basic Information
9.15.2 Pfizer Personalized Medicines Product Overview
9.15.3 Pfizer Personalized Medicines Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Sanofi
9.16.1 Sanofi Basic Information
9.16.2 Sanofi Personalized Medicines Product Overview
9.16.3 Sanofi Personalized Medicines Product Market Performance
9.16.4 Sanofi Business Overview
9.16.5 Sanofi Recent Developments
9.17 23andMe
9.17.1 23andMe Basic Information
9.17.2 23andMe Personalized Medicines Product Overview
9.17.3 23andMe Personalized Medicines Product Market Performance
9.17.4 23andMe Business Overview
9.17.5 23andMe Recent Developments
9.18 Illumina
9.18.1 Illumina Basic Information
9.18.2 Illumina Personalized Medicines Product Overview
9.18.3 Illumina Personalized Medicines Product Market Performance
9.18.4 Illumina Business Overview
9.18.5 Illumina Recent Developments
10 PERSONALIZED MEDICINES MARKET FORECAST BY REGION
10.1 Global Personalized Medicines Market Size Forecast
10.2 Global Personalized Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Personalized Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Personalized Medicines Market Size Forecast by Region
10.2.4 South America Personalized Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Personalized Medicines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Personalized Medicines Market Forecast by Type (2026-2035)
11.1.1 Global Personalized Medicines Market Size Forecast by Type (2026-2035)
11.2 Global Personalized Medicines Market Forecast by Application (2026-2035)
11.2.1 Global Personalized Medicines Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Medicines Market Size by Type (M USD)
Table 4. Global Personalized Medicines Market Size by Application
Table 5. Personalized Medicines Market Size Comparison by Region (M USD)
Table 6. Global Personalized Medicines Revenue (M USD) by Company (2020-2025)
Table 7. Global Personalized Medicines Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Personalized Medicines Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Personalized Medicines Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Personalized Medicines Market Size by Type (M USD)
Table 22. Global Personalized Medicines Market Size (M USD) by Type (2020-2025)
Table 23. Global Personalized Medicines Market Share by Type (2020-2025)
Table 24. Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
Table 25. Global Personalized Medicines Market Size by Application
Table 26. Global Personalized Medicines Market Size by Application (2020-2025) & (M USD)
Table 27. Global Personalized Medicines Market Share by Application (2020-2025)
Table 28. Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
Table 29. Global Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 30. Global Personalized Medicines Market Size Market Share by Region (2020-2025)
Table 31. North America Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 34. South America Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 36. 3G Biotech Basic Information
Table 37. 3G Biotech Personalized Medicines Product Overview
Table 38. 3G Biotech Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 39. 3G Biotech SWOT Analysis
Table 40. 3G Biotech Business Overview
Table 41. 3G Biotech Recent Developments
Table 42. Quest Diagnostics Basic Information
Table 43. Quest Diagnostics Personalized Medicines Product Overview
Table 44. Quest Diagnostics Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Quest Diagnostics SWOT Analysis
Table 46. Quest Diagnostics Business Overview
Table 47. Quest Diagnostics Recent Developments
Table 48. Laboratory Corporation of America Basic Information
Table 49. Laboratory Corporation of America Personalized Medicines Product Overview
Table 50. Laboratory Corporation of America Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Laboratory Corporation of America SWOT Analysis
Table 52. Laboratory Corporation of America Business Overview
Table 53. Laboratory Corporation of America Recent Developments
Table 54. Abbott Basic Information
Table 55. Abbott Personalized Medicines Product Overview
Table 56. Abbott Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Abbott Business Overview
Table 58. Abbott Recent Developments
Table 59. Agendia NV Basic Information
Table 60. Agendia NV Personalized Medicines Product Overview
Table 61. Agendia NV Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Agendia NV Business Overview
Table 63. Agendia NV Recent Developments
Table 64. Asuragen Inc Basic Information
Table 65. Asuragen Inc Personalized Medicines Product Overview
Table 66. Asuragen Inc Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Asuragen Inc Business Overview
Table 68. Asuragen Inc Recent Developments
Table 69. Becton Dickinson Basic Information
Table 70. Becton Dickinson Personalized Medicines Product Overview
Table 71. Becton Dickinson Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Becton Dickinson Business Overview
Table 73. Becton Dickinson Recent Developments
Table 74. CardioDx Inc. Basic Information
Table 75. CardioDx Inc. Personalized Medicines Product Overview
Table 76. CardioDx Inc. Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CardioDx Inc. Business Overview
Table 78. CardioDx Inc. Recent Developments
Table 79. Foundation Medicine Basic Information
Table 80. Foundation Medicine Personalized Medicines Product Overview
Table 81. Foundation Medicine Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Foundation Medicine Business Overview
Table 83. Foundation Medicine Recent Developments
Table 84. Qiagen Basic Information
Table 85. Qiagen Personalized Medicines Product Overview
Table 86. Qiagen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Qiagen Business Overview
Table 88. Qiagen Recent Developments
Table 89. Siemens Healthcare Basic Information
Table 90. Siemens Healthcare Personalized Medicines Product Overview
Table 91. Siemens Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Siemens Healthcare Business Overview
Table 93. Siemens Healthcare Recent Developments
Table 94. Amgen Basic Information
Table 95. Amgen Personalized Medicines Product Overview
Table 96. Amgen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Amgen Business Overview
Table 98. Amgen Recent Developments
Table 99. Bristol-Myers Squibb Basic Information
Table 100. Bristol-Myers Squibb Personalized Medicines Product Overview
Table 101. Bristol-Myers Squibb Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. GE Healthcare Basic Information
Table 105. GE Healthcare Personalized Medicines Product Overview
Table 106. GE Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 107. GE Healthcare Business Overview
Table 108. GE Healthcare Recent Developments
Table 109. Pfizer Basic Information
Table 110. Pfizer Personalized Medicines Product Overview
Table 111. Pfizer Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Pfizer Business Overview
Table 113. Pfizer Recent Developments
Table 114. Sanofi Basic Information
Table 115. Sanofi Personalized Medicines Product Overview
Table 116. Sanofi Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Sanofi Business Overview
Table 118. Sanofi Recent Developments
Table 119. 23andMe Basic Information
Table 120. 23andMe Personalized Medicines Product Overview
Table 121. 23andMe Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 122. 23andMe Business Overview
Table 123. 23andMe Recent Developments
Table 124. Illumina Basic Information
Table 125. Illumina Personalized Medicines Product Overview
Table 126. Illumina Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Illumina Business Overview
Table 128. Illumina Recent Developments
Table 129. Global Personalized Medicines Market Size Forecast by Region (2026-2035) & (M USD)
Table 130. North America Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Europe Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Asia Pacific Personalized Medicines Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Middle East and Africa Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Global Personalized Medicines Market Size Forecast by Type (2026-2035) & (M USD)
Table 136. Global Personalized Medicines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Medicines Market Size by Type (M USD)
Table 4. Global Personalized Medicines Market Size by Application
Table 5. Personalized Medicines Market Size Comparison by Region (M USD)
Table 6. Global Personalized Medicines Revenue (M USD) by Company (2020-2025)
Table 7. Global Personalized Medicines Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Personalized Medicines Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Personalized Medicines Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Personalized Medicines Market Size by Type (M USD)
Table 22. Global Personalized Medicines Market Size (M USD) by Type (2020-2025)
Table 23. Global Personalized Medicines Market Share by Type (2020-2025)
Table 24. Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
Table 25. Global Personalized Medicines Market Size by Application
Table 26. Global Personalized Medicines Market Size by Application (2020-2025) & (M USD)
Table 27. Global Personalized Medicines Market Share by Application (2020-2025)
Table 28. Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
Table 29. Global Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 30. Global Personalized Medicines Market Size Market Share by Region (2020-2025)
Table 31. North America Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 34. South America Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Personalized Medicines Market Size by Region (2020-2025) & (M USD)
Table 36. 3G Biotech Basic Information
Table 37. 3G Biotech Personalized Medicines Product Overview
Table 38. 3G Biotech Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 39. 3G Biotech SWOT Analysis
Table 40. 3G Biotech Business Overview
Table 41. 3G Biotech Recent Developments
Table 42. Quest Diagnostics Basic Information
Table 43. Quest Diagnostics Personalized Medicines Product Overview
Table 44. Quest Diagnostics Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Quest Diagnostics SWOT Analysis
Table 46. Quest Diagnostics Business Overview
Table 47. Quest Diagnostics Recent Developments
Table 48. Laboratory Corporation of America Basic Information
Table 49. Laboratory Corporation of America Personalized Medicines Product Overview
Table 50. Laboratory Corporation of America Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Laboratory Corporation of America SWOT Analysis
Table 52. Laboratory Corporation of America Business Overview
Table 53. Laboratory Corporation of America Recent Developments
Table 54. Abbott Basic Information
Table 55. Abbott Personalized Medicines Product Overview
Table 56. Abbott Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Abbott Business Overview
Table 58. Abbott Recent Developments
Table 59. Agendia NV Basic Information
Table 60. Agendia NV Personalized Medicines Product Overview
Table 61. Agendia NV Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Agendia NV Business Overview
Table 63. Agendia NV Recent Developments
Table 64. Asuragen Inc Basic Information
Table 65. Asuragen Inc Personalized Medicines Product Overview
Table 66. Asuragen Inc Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Asuragen Inc Business Overview
Table 68. Asuragen Inc Recent Developments
Table 69. Becton Dickinson Basic Information
Table 70. Becton Dickinson Personalized Medicines Product Overview
Table 71. Becton Dickinson Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Becton Dickinson Business Overview
Table 73. Becton Dickinson Recent Developments
Table 74. CardioDx Inc. Basic Information
Table 75. CardioDx Inc. Personalized Medicines Product Overview
Table 76. CardioDx Inc. Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 77. CardioDx Inc. Business Overview
Table 78. CardioDx Inc. Recent Developments
Table 79. Foundation Medicine Basic Information
Table 80. Foundation Medicine Personalized Medicines Product Overview
Table 81. Foundation Medicine Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Foundation Medicine Business Overview
Table 83. Foundation Medicine Recent Developments
Table 84. Qiagen Basic Information
Table 85. Qiagen Personalized Medicines Product Overview
Table 86. Qiagen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Qiagen Business Overview
Table 88. Qiagen Recent Developments
Table 89. Siemens Healthcare Basic Information
Table 90. Siemens Healthcare Personalized Medicines Product Overview
Table 91. Siemens Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Siemens Healthcare Business Overview
Table 93. Siemens Healthcare Recent Developments
Table 94. Amgen Basic Information
Table 95. Amgen Personalized Medicines Product Overview
Table 96. Amgen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Amgen Business Overview
Table 98. Amgen Recent Developments
Table 99. Bristol-Myers Squibb Basic Information
Table 100. Bristol-Myers Squibb Personalized Medicines Product Overview
Table 101. Bristol-Myers Squibb Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. GE Healthcare Basic Information
Table 105. GE Healthcare Personalized Medicines Product Overview
Table 106. GE Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 107. GE Healthcare Business Overview
Table 108. GE Healthcare Recent Developments
Table 109. Pfizer Basic Information
Table 110. Pfizer Personalized Medicines Product Overview
Table 111. Pfizer Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Pfizer Business Overview
Table 113. Pfizer Recent Developments
Table 114. Sanofi Basic Information
Table 115. Sanofi Personalized Medicines Product Overview
Table 116. Sanofi Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Sanofi Business Overview
Table 118. Sanofi Recent Developments
Table 119. 23andMe Basic Information
Table 120. 23andMe Personalized Medicines Product Overview
Table 121. 23andMe Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 122. 23andMe Business Overview
Table 123. 23andMe Recent Developments
Table 124. Illumina Basic Information
Table 125. Illumina Personalized Medicines Product Overview
Table 126. Illumina Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Illumina Business Overview
Table 128. Illumina Recent Developments
Table 129. Global Personalized Medicines Market Size Forecast by Region (2026-2035) & (M USD)
Table 130. North America Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Europe Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Asia Pacific Personalized Medicines Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Middle East and Africa Personalized Medicines Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Global Personalized Medicines Market Size Forecast by Type (2026-2035) & (M USD)
Table 136. Global Personalized Medicines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Personalized Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicines Market Size (M USD), 2025-2035
Figure 5. Global Personalized Medicines Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Personalized Medicines Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Personalized Medicines Product Life Cycle
Figure 12. Global Personalized Medicines Revenue Share by Company in 2025
Figure 13. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Personalized Medicines Revenue in 2025
Figure 15. Value Chain Map of Personalized Medicines
Figure 16. Global Personalized Medicines Market PEST Analysis
Figure 17. Global Personalized Medicines Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Personalized Medicines Market Share by Type
Figure 20. Market Share of Personalized Medicines by Type (2020-2025)
Figure 21. Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Personalized Medicines Market Share by Application
Figure 24. Global Personalized Medicines Market Share by Application (2020-2025)
Figure 25. Global Personalized Medicines Market Share by Application in 2024
Figure 26. Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Personalized Medicines Market Size Market Share by Region (2020-2025)
Figure 28. North America Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Personalized Medicines Market Size Market Share by Country in 2024
Figure 30. U.S. Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Personalized Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Personalized Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Personalized Medicines Market Share by Country in 2024
Figure 35. Germany Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Personalized Medicines Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Personalized Medicines Market Size Market Share by Region in 2024
Figure 42. China Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Personalized Medicines Market Size and Growth Rate (M USD)
Figure 48. South America Personalized Medicines Market Size Market Share by Country in 2024
Figure 49. Brazil Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Personalized Medicines Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Personalized Medicines Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Personalized Medicines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Personalized Medicines Market Share Forecast by Type (2026-2035)
Figure 61. Global Personalized Medicines Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Personalized Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicines Market Size (M USD), 2025-2035
Figure 5. Global Personalized Medicines Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Personalized Medicines Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Personalized Medicines Product Life Cycle
Figure 12. Global Personalized Medicines Revenue Share by Company in 2025
Figure 13. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Personalized Medicines Revenue in 2025
Figure 15. Value Chain Map of Personalized Medicines
Figure 16. Global Personalized Medicines Market PEST Analysis
Figure 17. Global Personalized Medicines Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Personalized Medicines Market Share by Type
Figure 20. Market Share of Personalized Medicines by Type (2020-2025)
Figure 21. Global Personalized Medicines Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Personalized Medicines Market Share by Application
Figure 24. Global Personalized Medicines Market Share by Application (2020-2025)
Figure 25. Global Personalized Medicines Market Share by Application in 2024
Figure 26. Global Personalized Medicines Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Personalized Medicines Market Size Market Share by Region (2020-2025)
Figure 28. North America Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Personalized Medicines Market Size Market Share by Country in 2024
Figure 30. U.S. Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Personalized Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Personalized Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Personalized Medicines Market Share by Country in 2024
Figure 35. Germany Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Personalized Medicines Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Personalized Medicines Market Size Market Share by Region in 2024
Figure 42. China Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Personalized Medicines Market Size and Growth Rate (M USD)
Figure 48. South America Personalized Medicines Market Size Market Share by Country in 2024
Figure 49. Brazil Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Personalized Medicines Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Personalized Medicines Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Personalized Medicines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Personalized Medicines Market Share Forecast by Type (2026-2035)
Figure 61. Global Personalized Medicines Market Share Forecast by Application (2026-2035)
More Publications
Global Network Communication Cable Market Research Report 2025(Status and Outlook)
US$ 3,200.00
September 2025
178 pages
Global Electronic Lab Notebook Market Research Report 2025(Status and Outlook)
US$ 3,200.00
September 2025
134 pages
Global Epoxy Thermistor Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
129 pages
Global Smartphone RF Front End Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
147 pages
Global PAM4 Optical DSP Market Research Report 2024(Status and Outlook)
US$ 3,200.00
January 2024
110 pages